Glenmark Pharmaceuticals Inc., USA recalls Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark Ph
Recalled July 27, 2022 · FDA recall D-1282-2022 · Glenmark Pharmaceuticals Inc., USA
Hazard
Failed Tablet/Capsule Specification : Capsule breakage · FDA Class III
Units
168936 bottles
Sold at
USA Nationwide
Description
Failed Tablet/Capsule Specification : Capsule breakage
Product
Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-405-60.
Manufacturer(s)
Glenmark Pharmaceuticals Inc., USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →